Literature DB >> 26126766

Three dimensional multi-cellular muscle-like tissue engineering in perfusion-based bioreactors.

Giulia Cerino1, Emanuele Gaudiello1, Thomas Grussenmeyer1, Ludovic Melly1, Diana Massai2, Andrea Banfi1, Ivan Martin1, Friedrich Eckstein1, Martin Grapow1, Anna Marsano3.   

Abstract

Conventional tissue engineering strategies often rely on the use of a single progenitor cell source to engineer in vitro biological models; however, multi-cellular environments can better resemble the complexity of native tissues. Previous described co-culture models used skeletal myoblasts, as parenchymal cell source, and mesenchymal or endothelial cells, as stromal component. Here, we propose instead the use of adipose tissue-derived stromal vascular fraction cells, which include both mesenchymal and endothelial cells, to better resemble the native stroma. Percentage of serum supplementation is one of the crucial parameters to steer skeletal myoblasts toward either proliferation (20%) or differentiation (5%) in two-dimensional culture conditions. On the contrary, three-dimensional (3D) skeletal myoblast culture often simply adopts the serum content used in monolayer, without taking into account the new cell environment. When considering 3D cultures of mm-thick engineered tissues, homogeneous and sufficient oxygen supply is paramount to avoid formation of necrotic cores. Perfusion-based bioreactor culture can significantly improve the oxygen access to the cells, enhancing the viability and the contractility of the engineered tissues. In this study, we first investigated the influence of different serum supplementations on the skeletal myoblast ability to proliferate and differentiate during 3D perfusion-based culture. We tested percentages of serum promoting monolayer skeletal myoblast-proliferation (20%) and differentiation (5%) and suitable for stromal cell culture (10%) with a view to identify the most suitable condition for the subsequent co-culture. The 10% serum medium composition resulted in the highest number of mature myotubes and construct functionality. Co-culture with stromal vascular fraction cells at 10% serum also supported the skeletal myoblast differentiation and maturation, hence providing a functional engineered 3D muscle model that resembles the native multi-cellular environment.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  bioreactor; perfusion; serum percentage; skeletal myoblasts; stromal cells; tissue engineering

Mesh:

Substances:

Year:  2015        PMID: 26126766     DOI: 10.1002/bit.25688

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  10 in total

1.  Ex-vivo assessment of drug response on breast cancer primary tissue with preserved microenvironments.

Authors:  Manuele G Muraro; Simone Muenst; Valentina Mele; Luca Quagliata; Giandomenica Iezzi; Alexandar Tzankov; Walter P Weber; Giulio C Spagnoli; Savas D Soysal
Journal:  Oncoimmunology       Date:  2017-05-30       Impact factor: 8.110

2.  In vitro biomimetic platforms featuring a perfusion system and 3D spheroid culture promote the construction of tissue-engineered corneal endothelial layers.

Authors:  Shanyi Li; Yuting Han; Hao Lei; Yingxin Zeng; Zekai Cui; Qiaolang Zeng; Deliang Zhu; Ruiling Lian; Jun Zhang; Zhe Chen; Jiansu Chen
Journal:  Sci Rep       Date:  2017-04-10       Impact factor: 4.379

3.  Sensitivity of human pluripotent stem cells to insulin precipitation induced by peristaltic pump-based medium circulation: considerations on process development.

Authors:  Diana Massai; Emiliano Bolesani; Diana Robles Diaz; Christina Kropp; Henning Kempf; Caroline Halloin; Ulrich Martin; Tudor Braniste; Giuseppe Isu; Vanessa Harms; Umberto Morbiducci; Gerald Dräger; Robert Zweigerdt
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

4.  Bioengineered constructs combined with exercise enhance stem cell-mediated treatment of volumetric muscle loss.

Authors:  Marco Quarta; Melinda Cromie; Robert Chacon; Justin Blonigan; Victor Garcia; Igor Akimenko; Mark Hamer; Patrick Paine; Merel Stok; Joseph B Shrager; Thomas A Rando
Journal:  Nat Commun       Date:  2017-06-20       Impact factor: 14.919

5.  Human tissue-engineered skeletal muscle: a novel 3D in vitro model for drug disposition and toxicity after intramuscular injection.

Authors:  D Gholobova; M Gerard; L Decroix; L Desender; N Callewaert; P Annaert; L Thorrez
Journal:  Sci Rep       Date:  2018-08-15       Impact factor: 4.379

6.  Application of 3D Printing Technology for Design and Manufacturing of Customized Components for a Mechanical Stretching Bioreactor.

Authors:  Giovanni Putame; Mara Terzini; Dario Carbonaro; Giuseppe Pisani; Gianpaolo Serino; Franca Di Meglio; Clotilde Castaldo; Diana Massai
Journal:  J Healthc Eng       Date:  2019-04-21       Impact factor: 2.682

7.  Polo-Like Kinase 2 is Dynamically Regulated to Coordinate Proliferation and Early Lineage Specification Downstream of Yes-Associated Protein 1 in Cardiac Progenitor Cells.

Authors:  Michika Mochizuki; Vera Lorenz; Robert Ivanek; Giacomo Della Verde; Emanuele Gaudiello; Anna Marsano; Otmar Pfister; Gabriela M Kuster
Journal:  J Am Heart Assoc       Date:  2017-10-24       Impact factor: 5.501

8.  Engineering of an angiogenic niche by perfusion culture of adipose-derived stromal vascular fraction cells.

Authors:  Giulia Cerino; Emanuele Gaudiello; Manuele Giuseppe Muraro; Friedrich Eckstein; Ivan Martin; Arnaud Scherberich; Anna Marsano
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

Review 9.  Next Stage Approach to Tissue Engineering Skeletal Muscle.

Authors:  Gregory Reid; Fabio Magarotto; Anna Marsano; Michela Pozzobon
Journal:  Bioengineering (Basel)       Date:  2020-09-30

10.  Perfusion-Based Bioreactor Culture and Isothermal Microcalorimetry for Preclinical Drug Testing with the Carbonic Anhydrase Inhibitor SLC-0111 in Patient-Derived Neuroblastoma.

Authors:  Zihe Huo; Remo Bilang; Claudiu T Supuran; Nicolas von der Weid; Elisabeth Bruder; Stefan Holland-Cunz; Ivan Martin; Manuele G Muraro; Stephanie J Gros
Journal:  Int J Mol Sci       Date:  2022-03-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.